A phase III, prospective, open-label, multi-center trial of ferric derisomaltose in children 0 to <18 years ofage with iron deficiency anemia due to non-dialysis dependent chronic kidney disease or with irondeficiency anemia who are intolerant or unres

Project: Research project

Project Details

Description

A phase III, prospective, open-label, multi-center trial of ferric derisomaltose in children 0 to <18 years of age with iron deficiency anemia due to non-dialysis dependent chronic kidney disease or with iron deficiency anemia who are intolerant or unres
StatusActive
Effective start/end date2/24/23 → 2/24/25

Funding

  • PHARMACOSMOS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint